S15-305 Novel AAV Capsids Resistant to Pre-existing Human Neutralizing Antibodies Researchers in Prof. Mark Kay's laboratory have continued to develop novel recombinant adeno-associated viral (AAV) capsids via capsid gene shuffling that transduce human hepatocytes at high efficiency in vivo. Nicole Paulk Mark Kay